Correlation of sexual desire with sexual hormone binding globulin and free androgen index in women using combined contraceptives

References

• Caruso S, Malandrino C, Cicero C, et al. Quality of sexual life of women on oral contraceptive continued-regimen: pilot study. J Sex Med. 2013;10(2):460–466. doi: 10.1111/j.1743-6109.2012.03004.x.
   PubMed Web of Science ®Google Scholar
• Malmborg A, Brynte L, Falk G, et al. Sexual function changes attributed to hormonal contraception use - a qualitative study of women experiencing negative effects. Eur J Contracept Reprod Health Care. 2020;25(3):169–175. doi: 10.1080/13625187.2020.1736545.
   PubMed Web of Science ®Google Scholar
• Caruso S, Palermo G, Caruso G, et al. How does contraceptive use affect women’s sexuality? A novel look at sexual acceptability. J Clin Med. 2022;11(3):810. doi: 10.3390/jcm11030810.
   PubMed Web of Science ®Google Scholar
• Whitton K, Baber R. Androgen-based therapies in women. Best Pract Res Clin Endocrinol Metab. 2023; May38(1):101783. doi: 10.1016/j.beem.2023.101783.
   PubMed Web of Science ®Google Scholar
• Bancroft J, Graham CA. The varied nature of women’s sexuality: unresolved issues and a theoretical approach. Horm Behav. 2011;59(5):717–729. doi: 10.1016/j.yhbeh.2011.01.005.
   PubMed Web of Science ®Google Scholar
• Wåhlin-Jacobsen S, Kristensen E, Pedersen AT, et al. Androgens and psychosocial factors related to sexual dysfunctions in premenopausal women∗: ∗2016 ISSM female sexual dysfunction prize. J Sex Med. 2017;14(3):366–379. doi: 10.1016/j.jsxm.2016.12.237.
   PubMed Web of Science ®Google Scholar
• Greco T, Graham CA, Bancroft J, et al. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol. Contraception. 2007;76(1):8–17. doi: 10.1016/j.contraception.2007.04.002.
   PubMed Web of Science ®Google Scholar
• Davis SR, Bitzer J, Giraldi A, et al. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction. J Sex Med. 2013;10(12):3069–3079. doi: 10.1111/jsm.12310.
   PubMed Web of Science ®Google Scholar
• Caruso S, Cianci S, Cariola M, et al. Improvement of low sexual desire due to antiandrogenic combined oral contraceptives after switching to an oral contraceptive containing 17β-Estradiol. J Womens Health (Larchmt). 2017;26(7):728–734. doi: 10.1089/jwh.2016.5801.
   PubMed Web of Science ®Google Scholar
• Schaffir J. Hormonal contraception and sexual desire: a critical review. J Sex Marital Ther. 2006;32(4):305–314. doi: 10.1080/00926230600666311.
   PubMed Web of Science ®Google Scholar
• Mansour D, Verhoeven C, Sommer W, et al. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen. Eur J Contracept Reprod Health Care. 2011;16(6):430–443. doi: 10.3109/13625187.2011.614029.
   PubMed Web of Science ®Google Scholar
• Odlind V, Milsom I, Persson I, et al. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand. 2002;81(6):482–490.
   PubMed Web of Science ®Google Scholar
• Zimmerman Y, Eijkemans MJ, Coelingh Bennink HJ, et al. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(1):76–105. doi: 10.1093/humupd/dmt038.
   PubMed Web of Science ®Google Scholar
• United Nations Department of Economic and Social Affairs Population Division. World contraceptive use. 2007. http://www.un.org/esa/population/publications/contraceptive2013/contraceptive_2013_table.pdf
   Google Scholar
• Rosenberg MJ, Meyers A, Roy V. Effi cacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations. Contraception. 1999;60(6):321–32 9. doi: 10.1016/s0010-7824(99)00109-2.
   PubMed Web of Science ®Google Scholar
• Hoffmann H, Moore C, Zimmermann H, et al. Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives. Exp Toxicol Pathol. 1998;50(4-6):458–464. doi: 10.1016/s0940-2993(98)80034-1.
   PubMedGoogle Scholar
• Hoy SM, Scott LJ. Estradiol valerate/dienogest in oral contraception. Drugs. 2009;69(12):1635–1646. doi: 10.2165/11202820-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Christin-Maitre S, Serfaty D, Chabbert-Buffet N, et al. Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17beta-estradiol (NOMAC/E2): a double-blind, randomized study. Hum Reprod. 2011;26(6):1338–1347. doi: 10.1093/humrep/der058.
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R, Nath A. Metabolic effects of contraceptive steroids. Rev Endocr Metab Disord. 2011;12(2):63–75. doi: 10.1007/s11154-011-9182-4.
   PubMed Web of Science ®Google Scholar
• Ågren UM, Anttila M, Mäenpää-Liukko K, et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. Eur J Contracept Reprod Health Care. 201116;16(6):444–457. doi: 10.3109/13625187.2011.604450.
   PubMed Web of Science ®Google Scholar
• Douxfils J, Morimont L, Gaspard U, et al. Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation. Thromb Res. 2022; Sep232:148–150. S0049-3848(22)00387-5 doi: 10.1016/j.thromres.2022.09.007.
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Cagnacci A, Chabbert-Buffet N, et al. A novel estetrol-containing combined oral contraceptive: european expert panel review. Eur J Contracept Reprod Health Care. 2022;27(5):373–383. doi: 10.1080/13625187.2022.2093850.
   PubMed Web of Science ®Google Scholar
• Mawet M, Maillard C, Klipping C, et al. Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives. Eur J Contracept Reprod Health Care. 2015;20(6):463–475. doi: 10.3109/13625187.2015.1068934.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Medical eligibility criteria for contraceptive use. 5th edition. Geneva: world Health Organization; 2015
   Google Scholar
• Parish SJ, Cottler-Casanova S, Clayton AH, et al. The evolution of the female sexual disorder/dysfunction definitions, nomenclature, and classifications: a review of DSM, ICSM, ISSWSH, and ICD. Sex Med Rev. 2021;9(1):36–56. doi: 10.1016/j.sxmr.2020.05.001.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Albani F, Vaccaro P, et al. Use of the italian translation of the female sexual function index (FSFI) in routine gynecological practice. Gynecol Endocrinol. 2008;24(4):214–219. doi: 10.1080/09513590801925596.
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Rosen R, Leiblum S, et al. The female sexual distress scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28(4):317–330. doi: 10.1080/00926230290001448.
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Perini D, Fornaciari L, et al. Discontinuation of modern hormonal contraceptives: an italian survey. Eur J Contracept Reprod Health Care. 2016;21(6):449–454. doi: 10.1080/13625187.2016.1234598.
   PubMed Web of Science ®Google Scholar
• Casado-Espada NM, de Alarcón R, de la Iglesia-Larrad JI, et al. Hormonal contraceptives, female sexual dysfunction, and managing strategies: a review. JCM. 2019;8(6):908. doi: 10.3390/jcm8060908.
   Google Scholar
• Both S, Lew-Starowicz M, Luria M, et al. Hormonal contraception and female sexuality: position statements from the European Society of Sexual Medicine (ESSM). J Sex Med. 2019;16(11):1681–1695. doi: 10.1016/j.jsxm.2019.08.005.
   Google Scholar
• Buggio L, Barbara G, Facchin F, Ghezzi L, Dridi D, Vercellini P. The influence of hormonal contraception on depression and female sexuality: a narrative review of the literature. Gynecol Endocrinol. 2022;38:193–201. doi: 10.1080/09513590.2021.2016693.
   PubMed Web of Science ®Google Scholar
• Caruso S, Agnello C, Malandrino C, et al. Do hormones influence women’s sex? Sexual activity over the menstrual cycle. J Sex Med. 2014;11(1):211–221. doi: 10.1111/jsm.12348.
   PubMed Web of Science ®Google Scholar
• Kennedy TG, Armstrong DT. Induction of vaginal mucification in rats with testosterone and 17β‐hydroxy‐5α‐androstan‐3‐one. Steroids. 1976;27(3):423–430. doi: 10.1016/0039-128x(76)90061-1.
   PubMed Web of Science ®Google Scholar
• Goldstein AT, Belkin ZR, Krapf JM, et al. Poly‐morphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med. 2014;11(11):2764–2771. doi: 10.1111/jsm.12668.
   PubMed Web of Science ®Google Scholar
• Handy AB, McMahon LN, Goldstein I, et al. Reduction in genital sexual arousal varies by type of oral contraceptive pill. J Sex Med. 2023;20(8):1094–1102. doi: 10.1093/jsxmed/qdad072.
   PubMed Web of Science ®Google Scholar
• Morgante G, Cappelli V, Troìa L, et al. Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome. Eur J Contracept Reprod Health Care. 2020;25(3):176–181. doi: 10.1080/13625187.2020.1736546.
   PubMed Web of Science ®Google Scholar
• Caruso S, Rugolo S, Agnello C, et al. Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate. J Sex Med. 2009;6(12):3376–3384. doi: 10.1111/j.1743-6109.2009.01529.x.
   PubMed Web of Science ®Google Scholar
• Wellings K, Brima N, Sadler K, et al. Stopping and switching contraceptive methods: findings from contessa, a prospective longitudinal study of women of reproductive age in England. Contraception. 2015;91(1):57–66. doi: 10.1016/j.contraception.2014.09.008.
   PubMed Web of Science ®Google Scholar
• De Leo V, Musacchio MC, Cappelli V, et al. Hormonal contraceptives: pharmacology tailored to women’s health. Hum Reprod Update. 2016;22(5):634–646. doi: 10.1093/humupd/dmw016.
   PubMed Web of Science ®Google Scholar